Ms Emma Sjöberg Sweden

The Elektrodress is a revolutionary body suit that increases the mobility and abilities for people with Cerebral Palsy or stroke. Inerventions AB was founded in 2010, based on the innovation Elektrodress. Inerventions has an accumulated turn over of 7,5MSEK in mid 2012, and roughly 330 patients using the treatment system. In november 2012 we will be finished with the regulatory requirements and start product sales on the Scandinavian Market.

Ms Emma Sjöberg
Inerventions
LinkedIn logo COO 

Mr Per Sköld Sweden

Business Type
Mr Per Sköld
Swedbank
VP Corporate Finance 

Mr Patric Stafshede Sweden

Likvor AB

Likvor is a medical device company which has developed a system to be used in neurological investigations assessing cerebrospinal fluid (CSF) dynamics. The LIKVOR CELDA® SYSTEM is on the market today.

Product

Likvor’s core product, the CELDA® Instrument is a device to measure the dynamics of the cerebrospinal fluid (“CSF”) system. With increased understanding of the brain and neurological diseases, mapping CSF dynamics is becoming more and more important. CELDA® Instrument offers automatic and standardized protocols for multiple purposes in the diagnostic process – identifying patients suffering from normal pressure hydrocephalus (“NPH”) with dementia like symptoms, mapping CSF dynamics pre- and post-shunt surgery, shunt control, constant flow or constant pressure measurements, tap tests, bolus infusions etc. It is the first and only CE certified instrument in this field and will enable objective comparisons of research data from different clinics and research groups. With its flexibility and easy handling the CELDA® sets a new standard for investigations of CSF-dynamics. CELDA® Instrument is safer for the patient and yields a faster and more accurate diagnosis.

By using the LIKVOR CELDA® SYSTEM hospitals can make huge savings, in costs as they reduce the number of shunt reoperations, and in human suffering.

Likvor AB is marketing the LIKVOR CELDA® SYSTEM and LIKVOR CELDA® TOOLS. The system includes an instrument, a bed and a disposable tube set. The system is the result of over 40 years of research at Umeå University and Umeå University Hospital assessing cerebrospinal fluid (CSF) dynamics. The company has one patent in the US and two patents pending which includes both method and device.

Potential and the market

Statistics show that 1 in 10 dementia patients suffer from NPH. Studies indicate that approximately 1.4 million patients in Europe, USA and Japan suffer from NPH.

The CELDA® SYSTEM was CE certified in 2009, and currently there are 8 systems in clinical use with paying customers in Sweden, Denmark, Finland and the UK. To reach the European market, distributors will be used, two contracts are signed; for the German- and the UK-market. A potential clinical study in the US is being evaluated.

Next step

Likvor is looking for 20 MSK for the next three years. The capital will be used to speed up the market penetration in Europe and recruit sales personnel. Exit could be possible through an industrial buyout, for example from a shunt company.  

Likvor

Mr Jan Stålemark Sweden

Obstecare AB

Dr Mårten Steen Sweden

Business Type
HealthCap

Dr Oern Stuge Sweden

Business Type
HealthCap

Dr Lovisa Sunesson Sweden

Invest in Skåne is the official inward investment agency for Skåne. Our mission is to promote international investment and trade in Southern Sweden. We help with partnerships and assist businesses in getting access to new markets. We pursue our mission by facilitating contacts with international corporations, and by promoting the Life Science expertise already present in the region.

With several years of experience in business development and life science, our team will assist your company in a simple 4-step process:

  1. We define your business and partnership goals and determine what technology, products and competencies you are looking for.
  2. We identify local companies, academic institutions and CMOs/CROs in your field highlighting potential business opportunities.
  3. We arrange a visiting programme where you can initiate explorative discussions with prospective business partners.
  4. We will support your efforts to successfully complete your partnership or investment project.
Dr Lovisa Sunesson
Invest in Skåne
LinkedIn logo Business Development Manager 

Mr Tobias Thornblad Sweden

Website:
www.dermafol.se
Business Type
Products
Dermafol AB
LinkedIn logo CEO 

Mr Peter Utterström Sweden

Business Type
Advokatfirman Delphi

Mr Timo Vallgren Sweden

Etteplan supports Medtech companies with design and development. ISO 13485 certified our 70 consultant engineers and designers help large and small companies develop products in all MDD Classes I-III from idea to production. Offices are located in Stockholm, Uppsala, Halmstad, Lund, Copenhagen and Helsinki offering the following engineering skills: Usability, Innovation Workshops, Industrial Design, Mechanical Engineering, Hardware/Software Development, Project Management, Regulatory Affairs and Documentation

Etteplan
Project Manager